These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 1819809)
61. [Clinical and serological observations of children vaccinated with measles vaccine and those not vaccinated during an epidemic in an inpatient institution]. Polna I; Szkudlarek D Pediatr Pol; 1979 Jan; 54(1):53-60. PubMed ID: 424255 [No Abstract] [Full Text] [Related]
62. The sero-epidemiology of measles in children from Eastern Turkey. Altinkaynak S; Ertekin V; Güraksin A; Kiliç A; Yiğit N West Indian Med J; 2005 Sep; 54(4):236-7. PubMed ID: 16312189 [No Abstract] [Full Text] [Related]
63. Declining measles antibodies in the era of elimination: Australia's experience. Gidding HF; Quinn HE; Hueston L; Dwyer DE; McIntyre PB Vaccine; 2018 Jan; 36(4):507-513. PubMed ID: 29269156 [TBL] [Abstract][Full Text] [Related]
64. [Revaccination of children inoculated against measles]. Bolotovskiĭ VM; Titova NS; Bakhur EA; Tamm OM; Miartin IaK Pediatriia; 1981 Dec; (12):46-8. PubMed ID: 7335425 [No Abstract] [Full Text] [Related]
66. Waning population immunity to measles in Taiwan. Chen CJ; Lee PI; Hsieh YC; Chen PY; Ho YH; Chang CJ; Liu DP; Chang FY; Chiu CH; Huang YC; Lee CY; Lin TY Vaccine; 2012 Oct; 30(47):6721-7. PubMed ID: 22634294 [TBL] [Abstract][Full Text] [Related]
67. [The immune response of children with an iron deficiency to vaccination with a live measles vaccine]. Kazakova LM; Makrushin IM; Tsvetova GV; Arsent'eva TN; Shabaldin AV Pediatriia; 1992; (7-9):36-7. PubMed ID: 1475138 [No Abstract] [Full Text] [Related]
68. Modelling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population. Mossong J; O'Callaghan CJ; Ratnam S Vaccine; 2000 Oct; 19(4-5):523-9. PubMed ID: 11027817 [TBL] [Abstract][Full Text] [Related]
69. [The results of multiyear observations on the duration of the maintenance of immunity in those vaccinated and revaccinated against and recovered from measles]. Sliusar' LI; Sokhin AA; Radomskaia FS; Degtiareva GV; Panasenko LI; Litvinova TP; Komarevskaia RV; Bol'shinskaia ZhI Zh Mikrobiol Epidemiol Immunobiol; 1990 Aug; (8):66-70. PubMed ID: 2239007 [TBL] [Abstract][Full Text] [Related]
70. Need for measles revaccination in adolescents: correlation with birth date prior to 1972. Yeager AS; Harvey B; Crosson FJ; Davis JH; Ross LA; Halonen PE J Pediatr; 1983 Feb; 102(2):191-5. PubMed ID: 6822921 [TBL] [Abstract][Full Text] [Related]
71. [Rapid serological screening of human sera for the presence of measles virus antibodies in solid-phase immunoenzyme analysis]. Vedunova SL Zh Mikrobiol Epidemiol Immunobiol; 1987 Sep; (9):81-5. PubMed ID: 3318248 [TBL] [Abstract][Full Text] [Related]
72. Comparative analysis of titers of antibody against measles virus in sera of vaccinated and naturally infected Japanese individuals of different age groups. Itoh M; Okuno Y; Hotta H J Clin Microbiol; 2002 May; 40(5):1733-8. PubMed ID: 11980952 [TBL] [Abstract][Full Text] [Related]
73. Immunity to measles in the Croatian population. Borcić B; Mazuran R; Kaić B Eur J Epidemiol; 2003; 18(11):1079-83. PubMed ID: 14620943 [TBL] [Abstract][Full Text] [Related]
75. Measles sero-immunity in rural non-vaccinated children of Busoga District, Uganda. Munube GM East Afr Med J; 1979 Jul; 56(7):335-8. PubMed ID: 520246 [No Abstract] [Full Text] [Related]
76. [Analysis of measles immunity level in persistent populations in Beijing, 2012]. Li J; Lu L; Chen M; Huang F; Zeng Y; Li XM; Ma R; Pan JB; Sun M; Sun H; Wang ZZ; Guo FR; Zhang YH; Wang FS; Wu T; Cui DJ; Peng XH; Wu J; Pang XH Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):916-9. PubMed ID: 24378131 [TBL] [Abstract][Full Text] [Related]
77. Measles virus-specific antibody levels in individuals in Argentina who received a one-dose vaccine. Argüelles MH; Orellana ML; Castello AA; Villegas GA; Masini M; Belizan AL; González Ayala S; Vera OD; Glikmann G J Clin Microbiol; 2006 Aug; 44(8):2733-8. PubMed ID: 16891485 [TBL] [Abstract][Full Text] [Related]
78. Seroepidemiological study on prevalence of measles antibodies in Urawa City. Tsuji A; Tanioku Y; Nakayama T Keio J Med; 1998 Dec; 47(4):209-11. PubMed ID: 9884515 [TBL] [Abstract][Full Text] [Related]
79. Seroepidemiological evaluation of 1989-91 mass vaccination campaigns against measles, in Italy. Grandolfo ME; Medda E; Novello F; Ridolfi B Epidemiol Infect; 1998 Dec; 121(3):645-52. PubMed ID: 10030715 [TBL] [Abstract][Full Text] [Related]
80. The declining antibody level of measles virus in China population, 2009-2015. Hu Y; Lu P; Deng X; Guo H; Zhou M BMC Public Health; 2018 Jul; 18(1):906. PubMed ID: 30041607 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]